DekaBank Deutsche Girozentrale’s ADMA Biologics ADMA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13M	Hold	236,178	–	–	﹤0.01%	688
2026 Q1	$2.17M	Hold	236,178	–	–	﹤0.01%	687
2025 Q4	$1.7M	Hold	236,178	–	–	﹤0.01%	794
2025 Q3	$1.69M	Hold	236,178	–	–	﹤0.01%	782
2025 Q2	$1.7M	Hold	236,178	–	–	﹤0.01%	772
2025 Q1	$1.59M	Hold	236,178	–	–	﹤0.01%	773
2024 Q4	$1.49M	Hold	236,178	–	–	﹤0.01%	805
2024 Q3	$1.55M	Hold	236,178	–	–	﹤0.01%	807
2024 Q2	$2.63M	Hold	236,178	–	–	﹤0.01%	702
2024 Q1	$1.59M	Hold	236,178	–	–	﹤0.01%	798
2023 Q4	$1.07M	Buy	236,178 +220,000	+1,360%	+$814K	﹤0.01%	889
2023 Q3	$58K	Buy	+16,178	New	+$62.3K	﹤0.01%	1375

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ADMA Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its ADMA Biologics (ADMA) position steady in Q2 2026 at 236,178 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #688.

DekaBank Deutsche Girozentrale first reported a position in ADMA in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.63M in Q2 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

DekaBank Deutsche Girozentrale held 236,178 shares of ADMA Biologics worth $2.13M as of Q2 2026.
DekaBank Deutsche Girozentrale left its ADMA Biologics share count unchanged in Q2 2026.
ADMA Biologics made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #688 holding.
DekaBank Deutsche Girozentrale first reported a position in ADMA Biologics in Q3 2023 and has held it in 12 quarters since.
DekaBank Deutsche Girozentrale's ADMA Biologics position peaked at $2.63M in Q2 2024.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.